Form 4 Filing for Agios Pharmaceuticals, Inc. - Officer/Director Transaction

This Form 4 filing reports a transaction by Catherine Owen Adams, a director at Agios Pharmaceuticals, Inc. On June 13, 2026, 1976 restricted stock units were granted, with a transaction code M and disposal code D, indicating a grant rather than a sale. The underlying security is Common stock, with 1976 shares. The transaction price was $0.0. Following this transaction, the post-transaction shares owned are 0. Additionally, there was a non-derivative transaction involving 1976 shares of Common stock acquired (code A) at a price of $0.0, resulting in 8049 shares owned post-transaction. The restricted stock units will vest in three equal annual installments starting June 13, 2024, with shares delivered within three business days of vesting. The filing is signed by William Cook as attorney-in-fact for Catherine Owen Adams.